130 related articles for article (PubMed ID: 17108691)
1. Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms.
Gómez-Esteban JC; Lezcano E; Zarranz JJ; Velasco F; Garamendi I; Pérez T; Tijero B
Eur Neurol; 2007; 57(1):26-30. PubMed ID: 17108691
[TBL] [Abstract][Full Text] [Related]
2. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic features of Huntington's disease-like 2.
Walker RH; Jankovic J; O'Hearn E; Margolis RL
Mov Disord; 2003 Dec; 18(12):1527-30. PubMed ID: 14673892
[TBL] [Abstract][Full Text] [Related]
4. Behavioral symptoms associated with Huntington's disease.
Anderson KE; Marshall FJ
Adv Neurol; 2005; 96():197-208. PubMed ID: 16383221
[TBL] [Abstract][Full Text] [Related]
5. The relationship between CAG repeat length and clinical progression in Huntington's disease.
Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic approaches to the treatment of Huntington's disease.
Venuto CS; McGarry A; Ma Q; Kieburtz K
Mov Disord; 2012 Jan; 27(1):31-41. PubMed ID: 21997232
[TBL] [Abstract][Full Text] [Related]
7. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
8. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
Landwehrmeyer GB; Dubois B; de Yébenes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
[TBL] [Abstract][Full Text] [Related]
9. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
[TBL] [Abstract][Full Text] [Related]
10. A clinical study of patients with genetically confirmed Huntington's disease from India.
Murgod UA; Saleem Q; Anand A; Brahmachari SK; Jain S; Muthane UB
J Neurol Sci; 2001 Sep; 190(1-2):73-8. PubMed ID: 11574110
[TBL] [Abstract][Full Text] [Related]
11. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
12. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
Curtis A; Mitchell I; Patel S; Ives N; Rickards H
Mov Disord; 2009 Nov; 24(15):2254-9. PubMed ID: 19845035
[TBL] [Abstract][Full Text] [Related]
13. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel.
Cao C; Temel Y; Blokland A; Ozen H; Steinbusch HW; Vlamings R; Nguyen HP; von Hörsten S; Schmitz C; Visser-Vandewalle V
Behav Brain Res; 2006 Jun; 170(2):257-61. PubMed ID: 16569446
[TBL] [Abstract][Full Text] [Related]
14. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.
Van Liew C; Gluhm S; Goldstein J; Cronan TA; Corey-Bloom J
Psychiatry; 2013; 76(4):323-35. PubMed ID: 24299091
[TBL] [Abstract][Full Text] [Related]
15. Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease.
Maroof DA; Gross AL; Brandt J
J Clin Exp Neuropsychol; 2011 Oct; 33(8):901-9. PubMed ID: 21644140
[TBL] [Abstract][Full Text] [Related]
16. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Robins Wahlin TB; Lundin A; Dear K
Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
[TBL] [Abstract][Full Text] [Related]
17. [Cognitive disorders in patients with Huntington's disease].
Barquero-Jiménez MS; Gómez-Tortosa E
Rev Neurol; 2001 Jun 1-15; 32(11):1067-71. PubMed ID: 11562832
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
[TBL] [Abstract][Full Text] [Related]
19. Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat.
Papapetropoulos S; Lopez-Alberola R; Baumbach L; Russell A; Gonzalez MA; Bowen BC; Singer C
Mov Disord; 2005 Oct; 20(10):1380-3. PubMed ID: 16007623
[TBL] [Abstract][Full Text] [Related]
20. Complex movement behaviour and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
